Epidemiology of Spondyloarthritis in North America
Abstract Many challenges have made it difficult to determine the prevalence of spondyloarthritis (SpA) in North America. They include the ethnic heterogeneity of the population, the lack of feasibility of applying current criteria (such as requirements for human leukocyte antigen-B27 testing and ima...
Gespeichert in:
| Veröffentlicht in: | The American journal of the medical sciences 2011-04, Vol.341 (4), p.284-286 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 286 |
|---|---|
| container_issue | 4 |
| container_start_page | 284 |
| container_title | The American journal of the medical sciences |
| container_volume | 341 |
| creator | Reveille, John D., MD |
| description | Abstract Many challenges have made it difficult to determine the prevalence of spondyloarthritis (SpA) in North America. They include the ethnic heterogeneity of the population, the lack of feasibility of applying current criteria (such as requirements for human leukocyte antigen-B27 testing and imaging studies such as pelvic radiographs and magnetic resonance imaging scanning) and the transient nature of some SpA symptoms (ie, peripheral arthritis and enthesitis). Current estimates of the prevalence of SpA in the United States range between 0.2% and 0.5% for ankylosing spondylitis, 0.1% for psoriatic arthritis, 0.065% for enteropathic peripheral arthritis, between 0.05% and 0.25% for enteropathic axial arthritis and an overall prevalence of SpA as high as > 1%. With newer population-based instruments becoming available, the availability of the widely validated European Spondyloarthropathy Study Group criteria and the lower cost and greater feasibility of genetic testing, opportunities for true population-based studies of SpA are possible and will likely soon ensue. |
| doi_str_mv | 10.1097/MAJ.0b013e31820f8c99 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3063892</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002962915313197</els_id><sourcerecordid>858776021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c613t-61553731ef610c5305e4a0fe6a87b35beea6d486ee4a7f26969946b20d84a8d13</originalsourceid><addsrcrecordid>eNqFUk1v1DAQtRCILoV_gFAuiFPK-DP2BWlVlS8VOBTOluNMWhcnXuxspf33eNWlhV44WeN582bmzSPkJYUTCqZ7-2X9-QR6oBw51QxG7Y15RFZUct0yY-AxWQEAa41i5og8K-UagDJN-VNyxKjgIIRYEXa2CQNOIcV0uWvS2Fxs0jzsYnJ5ucphCaUJc_M11ahZT5iDd8_Jk9HFgi8O7zH58f7s--nH9vzbh0-n6_PWK8qXVlEpeccpjoqClxwkCgcjKqe7nsse0alBaIX1uxuZMsoYoXoGgxZOD5Qfk3e3vJttP-HgcV6yi3aTw-TyziYX7L-ZOVzZy3RjOSiuDasEbw4EOf3aYlnsFIrHGN2MaVuslrrrFLB9K3GL9DmVknG860LB7tW2VW37UO1a9urvCe-K_shbAa8PAFe8i2N2sw_lHidASanE_apY9bwJmG3xAWePQ8joFzuk8L9JHhL4GOZ6rPgTd1iu0zbP9VaW2sIs2Iu9M_bGqG6hnJqO_wasXrIe</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>858776021</pqid></control><display><type>article</type><title>Epidemiology of Spondyloarthritis in North America</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Reveille, John D., MD</creator><creatorcontrib>Reveille, John D., MD</creatorcontrib><description>Abstract Many challenges have made it difficult to determine the prevalence of spondyloarthritis (SpA) in North America. They include the ethnic heterogeneity of the population, the lack of feasibility of applying current criteria (such as requirements for human leukocyte antigen-B27 testing and imaging studies such as pelvic radiographs and magnetic resonance imaging scanning) and the transient nature of some SpA symptoms (ie, peripheral arthritis and enthesitis). Current estimates of the prevalence of SpA in the United States range between 0.2% and 0.5% for ankylosing spondylitis, 0.1% for psoriatic arthritis, 0.065% for enteropathic peripheral arthritis, between 0.05% and 0.25% for enteropathic axial arthritis and an overall prevalence of SpA as high as > 1%. With newer population-based instruments becoming available, the availability of the widely validated European Spondyloarthropathy Study Group criteria and the lower cost and greater feasibility of genetic testing, opportunities for true population-based studies of SpA are possible and will likely soon ensue.</description><identifier>ISSN: 0002-9629</identifier><identifier>EISSN: 1538-2990</identifier><identifier>DOI: 10.1097/MAJ.0b013e31820f8c99</identifier><identifier>PMID: 21430444</identifier><identifier>CODEN: AJMSA9</identifier><language>eng</language><publisher>Hagerstown, MD: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Ankylosing spondylitis ; Arthritis, Psoriatic - epidemiology ; Biological and medical sciences ; Enteropathic arthritis ; Epidemiology ; Female ; General aspects ; Humans ; Internal Medicine ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; North America - epidemiology ; Nutrition Surveys ; Prevalence ; Psoriatic arthritis ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Retrospective Studies ; Spondylarthritis - epidemiology ; Spondylitis, Ankylosing - epidemiology ; Spondyloarthritis ; United States - epidemiology ; Young Adult</subject><ispartof>The American journal of the medical sciences, 2011-04, Vol.341 (4), p.284-286</ispartof><rights>Southern Society for Clinical Investigation</rights><rights>2011 Southern Society for Clinical Investigation</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c613t-61553731ef610c5305e4a0fe6a87b35beea6d486ee4a7f26969946b20d84a8d13</citedby><cites>FETCH-LOGICAL-c613t-61553731ef610c5305e4a0fe6a87b35beea6d486ee4a7f26969946b20d84a8d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,309,310,314,776,780,785,786,881,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24065564$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21430444$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reveille, John D., MD</creatorcontrib><title>Epidemiology of Spondyloarthritis in North America</title><title>The American journal of the medical sciences</title><addtitle>Am J Med Sci</addtitle><description>Abstract Many challenges have made it difficult to determine the prevalence of spondyloarthritis (SpA) in North America. They include the ethnic heterogeneity of the population, the lack of feasibility of applying current criteria (such as requirements for human leukocyte antigen-B27 testing and imaging studies such as pelvic radiographs and magnetic resonance imaging scanning) and the transient nature of some SpA symptoms (ie, peripheral arthritis and enthesitis). Current estimates of the prevalence of SpA in the United States range between 0.2% and 0.5% for ankylosing spondylitis, 0.1% for psoriatic arthritis, 0.065% for enteropathic peripheral arthritis, between 0.05% and 0.25% for enteropathic axial arthritis and an overall prevalence of SpA as high as > 1%. With newer population-based instruments becoming available, the availability of the widely validated European Spondyloarthropathy Study Group criteria and the lower cost and greater feasibility of genetic testing, opportunities for true population-based studies of SpA are possible and will likely soon ensue.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Ankylosing spondylitis</subject><subject>Arthritis, Psoriatic - epidemiology</subject><subject>Biological and medical sciences</subject><subject>Enteropathic arthritis</subject><subject>Epidemiology</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>North America - epidemiology</subject><subject>Nutrition Surveys</subject><subject>Prevalence</subject><subject>Psoriatic arthritis</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Retrospective Studies</subject><subject>Spondylarthritis - epidemiology</subject><subject>Spondylitis, Ankylosing - epidemiology</subject><subject>Spondyloarthritis</subject><subject>United States - epidemiology</subject><subject>Young Adult</subject><issn>0002-9629</issn><issn>1538-2990</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUk1v1DAQtRCILoV_gFAuiFPK-DP2BWlVlS8VOBTOluNMWhcnXuxspf33eNWlhV44WeN582bmzSPkJYUTCqZ7-2X9-QR6oBw51QxG7Y15RFZUct0yY-AxWQEAa41i5og8K-UagDJN-VNyxKjgIIRYEXa2CQNOIcV0uWvS2Fxs0jzsYnJ5ucphCaUJc_M11ahZT5iDd8_Jk9HFgi8O7zH58f7s--nH9vzbh0-n6_PWK8qXVlEpeccpjoqClxwkCgcjKqe7nsse0alBaIX1uxuZMsoYoXoGgxZOD5Qfk3e3vJttP-HgcV6yi3aTw-TyziYX7L-ZOVzZy3RjOSiuDasEbw4EOf3aYlnsFIrHGN2MaVuslrrrFLB9K3GL9DmVknG860LB7tW2VW37UO1a9urvCe-K_shbAa8PAFe8i2N2sw_lHidASanE_apY9bwJmG3xAWePQ8joFzuk8L9JHhL4GOZ6rPgTd1iu0zbP9VaW2sIs2Iu9M_bGqG6hnJqO_wasXrIe</recordid><startdate>20110401</startdate><enddate>20110401</enddate><creator>Reveille, John D., MD</creator><general>Elsevier Inc</general><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110401</creationdate><title>Epidemiology of Spondyloarthritis in North America</title><author>Reveille, John D., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c613t-61553731ef610c5305e4a0fe6a87b35beea6d486ee4a7f26969946b20d84a8d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Ankylosing spondylitis</topic><topic>Arthritis, Psoriatic - epidemiology</topic><topic>Biological and medical sciences</topic><topic>Enteropathic arthritis</topic><topic>Epidemiology</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>North America - epidemiology</topic><topic>Nutrition Surveys</topic><topic>Prevalence</topic><topic>Psoriatic arthritis</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Retrospective Studies</topic><topic>Spondylarthritis - epidemiology</topic><topic>Spondylitis, Ankylosing - epidemiology</topic><topic>Spondyloarthritis</topic><topic>United States - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reveille, John D., MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of the medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reveille, John D., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiology of Spondyloarthritis in North America</atitle><jtitle>The American journal of the medical sciences</jtitle><addtitle>Am J Med Sci</addtitle><date>2011-04-01</date><risdate>2011</risdate><volume>341</volume><issue>4</issue><spage>284</spage><epage>286</epage><pages>284-286</pages><issn>0002-9629</issn><eissn>1538-2990</eissn><coden>AJMSA9</coden><abstract>Abstract Many challenges have made it difficult to determine the prevalence of spondyloarthritis (SpA) in North America. They include the ethnic heterogeneity of the population, the lack of feasibility of applying current criteria (such as requirements for human leukocyte antigen-B27 testing and imaging studies such as pelvic radiographs and magnetic resonance imaging scanning) and the transient nature of some SpA symptoms (ie, peripheral arthritis and enthesitis). Current estimates of the prevalence of SpA in the United States range between 0.2% and 0.5% for ankylosing spondylitis, 0.1% for psoriatic arthritis, 0.065% for enteropathic peripheral arthritis, between 0.05% and 0.25% for enteropathic axial arthritis and an overall prevalence of SpA as high as > 1%. With newer population-based instruments becoming available, the availability of the widely validated European Spondyloarthropathy Study Group criteria and the lower cost and greater feasibility of genetic testing, opportunities for true population-based studies of SpA are possible and will likely soon ensue.</abstract><cop>Hagerstown, MD</cop><pub>Elsevier Inc</pub><pmid>21430444</pmid><doi>10.1097/MAJ.0b013e31820f8c99</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9629 |
| ispartof | The American journal of the medical sciences, 2011-04, Vol.341 (4), p.284-286 |
| issn | 0002-9629 1538-2990 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3063892 |
| source | MEDLINE; Alma/SFX Local Collection; Journals@Ovid Complete |
| subjects | Adolescent Adult Aged Aged, 80 and over Ankylosing spondylitis Arthritis, Psoriatic - epidemiology Biological and medical sciences Enteropathic arthritis Epidemiology Female General aspects Humans Internal Medicine Male Medical sciences Middle Aged Miscellaneous North America - epidemiology Nutrition Surveys Prevalence Psoriatic arthritis Public health. Hygiene Public health. Hygiene-occupational medicine Retrospective Studies Spondylarthritis - epidemiology Spondylitis, Ankylosing - epidemiology Spondyloarthritis United States - epidemiology Young Adult |
| title | Epidemiology of Spondyloarthritis in North America |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T05%3A03%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiology%20of%20Spondyloarthritis%20in%20North%20America&rft.jtitle=The%20American%20journal%20of%20the%20medical%20sciences&rft.au=Reveille,%20John%20D.,%20MD&rft.date=2011-04-01&rft.volume=341&rft.issue=4&rft.spage=284&rft.epage=286&rft.pages=284-286&rft.issn=0002-9629&rft.eissn=1538-2990&rft.coden=AJMSA9&rft_id=info:doi/10.1097/MAJ.0b013e31820f8c99&rft_dat=%3Cproquest_pubme%3E858776021%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=858776021&rft_id=info:pmid/21430444&rft_els_id=S0002962915313197&rfr_iscdi=true |